NeuroOne Medical Technologies Corporation Common Stock NMTC

$1.83 +20.39% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q QUARTERLY REPORT 2026-08-13 View →
8-K CURRENT REPORT 2026-08-13 View →
4 PRIMARY DOCUMENT 2026-07-02 View →
424B5 PROSPECTUS SUPPLEMENT 2026-06-12 View →
8-K CURRENT REPORT 2026-06-12 View →
8-K CURRENT REPORT 2026-05-22 View →
10-Q QUARTERLY REPORT 2026-05-12 View →
8-K CURRENT REPORT 2026-05-12 View →
8-K CURRENT REPORT 2026-05-04 View →
8-K CURRENT REPORT 2026-04-30 View →
8-K CURRENT REPORT 2026-04-14 View →
4 PRIMARY DOCUMENT 2026-04-07 View →
4 PRIMARY DOCUMENT 2026-04-07 View →
4 PRIMARY DOCUMENT 2026-04-07 View →
4 PRIMARY DOCUMENT 2026-04-07 View →
8-K CURRENT REPORT 2026-04-03 View →
4 PRIMARY DOCUMENT 2026-04-01 View →
4 PRIMARY DOCUMENT 2026-04-01 View →
4 PRIMARY DOCUMENT 2026-04-01 View →
4 PRIMARY DOCUMENT 2026-03-16 View →
4 PRIMARY DOCUMENT 2026-03-12 View →
DEF 14A PROXY STATEMENT 2026-03-09 View →
4 PRIMARY DOCUMENT 2026-03-03 View →
8-K CURRENT REPORT 2026-02-25 View →
4 PRIMARY DOCUMENT 2026-02-20 View →
4 PRIMARY DOCUMENT 2026-02-20 View →
4 PRIMARY DOCUMENT 2026-02-20 View →
8-K CURRENT REPORT 2026-02-17 View →
10-Q QUARTERLY REPORT 2026-02-17 View →
4 PRIMARY DOCUMENT 2026-01-05 View →
4 PRIMARY DOCUMENT 2026-01-05 View →
4 PRIMARY DOCUMENT 2026-01-05 View →
4 PRIMARY DOCUMENT 2026-01-02 View →
8-K CURRENT REPORT 2025-12-22 View →
8-K CURRENT REPORT 2025-12-17 View →
10-K ANNUAL REPORT 2025-12-17 View →
8-K CURRENT REPORT 2025-11-05 View →
8-K CURRENT REPORT 2025-10-06 View →
4 PRIMARY DOCUMENT 2025-10-01 View →
4 PRIMARY DOCUMENT 2025-10-01 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.83
Market Cap
$13.23 million
52-Week Range
$1.42 $6.96
Average Volume
66K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.